Sicca syndrome, also known as Sj�gren�s syndrome, is a chronic autoimmune disorder that affects the body�s ability to produce tears and saliva. It is estimated that 1.6 million Americans are affected by the disorder, and it is more commonly found in women between the ages of 40 and 60. While the exact cause of Sicca syndrome is unknown, it is believed to be related to a combination of genetic and environmental factors. For doctors, understanding the complexity of Sicca syndrome is essential to properly diagnose and treat the condition.
The most common symptoms of Sicca syndrome are dry eyes and dry mouth. Other symptoms may include fatigue, joint pain, skin rashes, difficulty swallowing, and dryness of the nose, throat, and vagina. In some cases, Sicca syndrome may also be associated with other autoimmune disorders such as lupus, rheumatoid arthritis, and thyroid disease.
In order to diagnose Sicca syndrome, doctors must first take a comprehensive medical history and perform a physical examination. The physical examination may include an eye exam to look for signs of dryness, and tests to measure the amount of tears and saliva produced. In some cases, doctors may also order blood tests to check for antibodies that are associated with Sicca syndrome.
Once diagnosed, treatment for Sicca syndrome will depend on the severity of the condition and the individual�s symptoms. In mild cases, doctors may recommend lifestyle changes such as drinking more water and using artificial tears or saliva substitutes. For more severe cases, doctors may prescribe medications such as anti-inflammatory drugs, immunosuppressants, and biologic agents. In some cases, doctors may also recommend physical therapy or surgery to treat the condition.
In addition to medical treatments, there are a number of lifestyle changes that can help manage the symptoms of Sicca syndrome. These include avoiding dry environments, using a humidifier, avoiding spicy and acidic foods, and avoiding alcohol and caffeine. It is also important to practice good oral hygiene and to use a soft toothbrush to avoid irritating the mouth.
Sicca syndrome is a complex autoimmune disorder that affects the body�s ability to produce tears and saliva. While the exact cause of the condition is unknown, it is believed to be related to a combination of genetic and environmental factors. For doctors, understanding the complexity of Sicca syndrome is essential to properly diagnose and treat the condition. Treatment options for Sicca syndrome may include lifestyle changes, medications, physical therapy, and surgery. In addition, there are a number of lifestyle changes that can help manage the symptoms of Sicca syndrome.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation